69 Best Biotech Startups to Watch in 2024
The Definitive Seedtable Ranking of Biotech Startups
We track 18,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
Our database reveals 979 cutting-edge startups in the Biotech industry, showcasing a vibrant ecosystem of innovation.
We've compiled profiles on 397 founders and executives for these startups, providing unparalleled access to key decision-makers.
Last update to the database: Sep 24, 2024. See changelog.
Displaying 69 out of 979 Companies
| Company | Score | Funding | Investors | Employees | Industries | Business Model | Location | Likely To Outsource | Contact | |
|---|---|---|---|---|---|---|---|---|---|---|
Myricx Bio Antibody-drug conjugate (ADC) payload platform. | 75 | $115M Series A | 4 | 1 to 10 | Biotech | London, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | r********r@myricxpharma.com | ||
Pheon Therapeutics Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers. | 70 | $188M Series B | 4 | 11 to 50 | Biotech | London, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | c***s@pheontx.com | ||
ITM Developer of radiomolecular precision therapeutics and diagnostics for treatment of tumors. | 67 | $205M Series D | 4 | 501 to 1000 | Biotech | Munich, Germany | Cybersecurity, Branding, Management Consulting, Sales, Hi... | s**************r@itm-radiopharma.com | ||
Beacon Therapeutics Oophthalmic gene therapy company to treat blinding retinal illnesses. | 63 | $120M Series A | 1 | 1 to 10 | Biotech | London, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | a****e@beacontx.com | ||
Achilles Therapeutics Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. | 60 | $201M Series C | 6 | 101 to 250 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | i***i@achillestx.com | ||
Causaly Biomedical research discovery tool. | 60 | $78.2M Series B | 4 | 51 to 100 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | y*****s@causaly.com | ||
Lifebit Biomedical CloudOS data platform. | 60 | $67.6M Series B | 4 | 51 to 100 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | m***a@lifebit.ai | ||
Mnemo Therapeutics Biotechnology firm focused on life science advancements. | 60 | $89.6M Series A | 1 | 101 to 250 | Biotech | Paris, France | Cybersecurity, Branding, Management Consulting, Sales, Hi... | r***********e@mnemo-tx.com | ||
Ori Biotech Manufacturing platform designed to help patients access lifesaving treatments. | 60 | $130M Series B | 3 | 1 to 10 | Biotech | London, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | s**********e@oribiotech.com | ||
Quell Therapeutics Cell therapy firm specializing in developing treatments using advanced cellular technology. | 60 | $201M Series B | 2 | 101 to 250 | Biotech | London, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | i******l@quell-tx.com | ||
Tissium Niodegradable sealants and adhesives for wound closure. | 60 | $163M Series D | 7 | 51 to 100 | Biotech | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | r*****d@tissium.com | ||
Complement Therapeutics Preclinical stage treatment for geographic atrophy. | 60 | $79.0M Series A | 2 | 1 to 10 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | m******s@complementtx.com | ||
Apollo Therapeutics Portfolio of pharmaceutical research and discovery. | 60 | $33.5M Series C | 3 | 1 to 10 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | j************o@apollotherapeutics.com | ||
Corteria Pharmaceuticals Interceptive therapies for heart failure subpopulations. | 60 | $82.4M Series A | 3 | 1 to 10 | Biotech | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | p***********k@corteriapharma.com | ||
FA Bio Discovery and development platform of superior microbial bioproducts. | 60 | $7.2M Series A | 2 | 1 to 10 | Biotech | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | |||
Insempra Advanced bio-based ingredients manufacturer. | 60 | $35.0M Series A | 5 | 11 to 50 | Biotech | Munich, Germany | Marketing, Software Engineering, Marketing, Branding, Man... | |||
e-therapeutics Computational drug discovery platform. | 60 | $37.0M Series B | 1 | 11 to 50 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | a***********i@etherapeutics.co.uk | ||
CatalYm Innovative immunotherapies developer for cancer patients. | 56 | $260M Series D | 8 | 11 to 50 | Biotech | Munich, Germany | Cybersecurity, Branding, Management Consulting, Sales, Hi... | p************r@catalym.com | ||
LabGenius Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine. | 56 | $83.2M Series B | 9 | 51 to 100 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | j***s@labgeni.us | ||
Leyden Labs Manufacturer of medicines to protect from the threat of respiratory viruses | 56 | $187M Series B | 2 | 11 to 50 | Biotech | Amsterdam, Netherlands | Cybersecurity, Branding, Management Consulting, Sales, Hi... | k***************p@leydenlabs.com | ||
Mainstay Medical Manufacturer of medical devices for mechanical Chronic Low Back Pain (CLBP). | 56 | $184M Debt Financing | 5 | 101 to 250 | Biotech | Dublin, Ireland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | j**********n@mainstay-medical.com | ||
MinervaX Developer of prophylactic vaccine against Group B Streptococcus. | 56 | $176M Series C | 9 | 1 to 10 | Biotech | Copenhagen, Denmark | Hiring, Marketing, Software Engineering, Cybersecurity, B... | p*f@minervax.com | ||
Minoryx Therapeutics Drugs discovery platform for orphan diseases. | 56 | $104M Series C | 10 | 11 to 50 | Biotech | Barcelona, Spain | Hiring, Marketing, Software Engineering, Cybersecurity, B... | m********l@minoryx.com | ||
NorthSea Therapeutics Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases. | 56 | $146M Series C | 4 | 11 to 50 | Biotech | Amsterdam, Netherlands | Hiring, Marketing, Software Engineering, Cybersecurity, B... | c***********n@northseatherapeutics.com | ||
Step Pharma Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1). | 56 | $59.7M Series B | 4 | 1 to 10 | Biotech | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | *****@step-ph.com | ||
SynOx Therapeutics Developer of treatment for diffuse tenosynovial giant cell tumors. | 56 | $118M Series B | 5 | 1 to 10 | Biotech | Dublin, Ireland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | s*********e@synoxtherapeutics.com | ||
Tubulis Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases. | 56 | $216M Series B | 8 | 11 to 50 | Biotech | Munich, Germany | Cybersecurity, Branding, Management Consulting, Sales, Hi... | d****************r@tubulis.com | ||
VectorY Antibody therapeutics treatment for neurodegenerative diseases. | 56 | $171M Series A | 6 | 51 to 200 | Biotech | Amsterdam, Netherlands | Cybersecurity, Branding, Management Consulting, Sales, Hi... | b*************s@vectorytx.com | ||
Eligo Bioscience Gene-editing platform. | 56 | $50.8M Series B | 4 | 11 to 50 | Biotech | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | x*************t@eligo-bioscience.com | ||
Formo Lab-made cheese maker. | 56 | $50.5M Series A | 8 | 11 to 50 | Biotech | Berlin, Germany | Hiring, Marketing, Software Engineering, Cybersecurity, B... | r*****l@formo.bio | ||
Neurosterix Advanced allosteric modulator therapeutics developer for neurological disorders. | 56 | $63.0M Series A | 3 | 1 to 10 | Biotech | Geneva, Switzerland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | |||
Alira Health International advisory firm for healthcare sector. | 53 | $93.0M Series C | 101 to 250 | Biotech | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | g****************a@alirahealth.com | |||
Ascend Gene & Cell Therapies Gene and cell therapy manufacturing. | 53 | $65.9M Series A | 11 to 50 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | m***********i@ascend-gctx.com | |||
SciRhom iRhom2 antibodies developer for better treatment of autoimmune diseases. | 53 | $68.3M Series A | 4 | 1 to 10 | Biotech | , | Hiring, Marketing, Software Engineering, Cybersecurity, B... | r**e@scirhom.com | ||
Adionics Eco-friendly liquid-liquid direct lithium extraction (DLE) process developer. | 52 | $35.5M Series B | 4 | 11 to 50 | Biotech | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | d**************e@adionics.com | ||
Aqemia Drug discovery platform. | 52 | $43.8M Series A | 4 | 51 to 100 | Biotech | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | m*****************e@aqemia.com | ||
Ariceum Therapeutics Diagnosis and treatment of hard-to-treat cancers. | 52 | $25.0M Series A | 4 | 11 to 50 | Biotech | Berlin, Germany | Marketing, Software Engineering, Marketing, Branding, Man... | g******n@ariceum-therapeutics.com | ||
Better Dairy Building the future of food, starting with dairy. | 52 | $24.1M Unknown | 4 | 1 to 10 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | j***n@betterdairy.co.uk | ||
Charm Therapeutics Platform using deep learning on 3D molecular structures to develop treatments for harmful proteins. | 52 | $50.0M Series A | 2 | 1 to 10 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | r**a@charmtx.com | ||
Coave Therapeutics Gene therapies for rare diseases. | 52 | $25.8M Series B | 6 | 11 to 50 | Biotech | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | r******l@coavetx.com | ||
Egle Therapeutics Biotechnology firm developing immunotherapies for cancer and autoimmune diseases. | 52 | $46.2M Unknown | 1 | 11 to 50 | Biotech | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | l*****t@egle-tx.com | ||
ENYO Pharma Vonafexor drug maker for the treatment of Alport syndrome. | 52 | $110M Series C | 5 | 1 to 10 | Biotech | Lyon, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | *****@enyopharma.com | ||
Epsilogen Immuno-oncology company treats cancer with antibodies. | 52 | $44.2M Unknown | 3 | 11 to 50 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | t*m@epsilogen.com | ||
Hemab Treatments for genetic bleeding disorders. | 52 | $190M Series B | 2 | 1 to 10 | Biotech | Copenhagen, Denmark | Cybersecurity, Branding, Management Consulting, Sales, Hi... | t**a@hemab.com | ||
Hoxton Farms Cultivated fat producer for the meat alternatives industry. | 52 | $25.7M Series A | 2 | 11 to 50 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | *****@hoxtonfarms.com | ||
ImmunOs Therapeutics Immunotherapy platform for cancer. | 52 | $93.3M Unknown | 4 | 11 to 50 | Biotech | Zürich, Switzerland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | s********h@immunostherapeutics.com | ||
IO Biotech Clinical-stage biotech company developing immune therapies for cancer treatment. | 52 | $163M Series B | 2 | 11 to 50 | Biotech | Copenhagen, Denmark | Cybersecurity, Branding, Management Consulting, Sales, Hi... | *****@iobiotech.com | ||
Labster E-learning platform providing virtual laboratory simulations using mathematical algorithms. | 52 | $90.0M Series C | 7 | 101 to 250 | Biotech | Copenhagen, Denmark | Hiring, Marketing, Software Engineering, Cybersecurity, B... | a***u@labster.com | ||
Muna Therapeutics Therapies that slow or stop neurodegenerative diseases such as Alzheimer's and Parkinson's. | 52 | $75.4M Series A | 4 | Biotech | Copenhagen, Denmark | Hiring, Marketing, Software Engineering, Cybersecurity, B... | b**********n@munatherapeutics.com | |||
Onego Bio Animal-free egg protein producer for food manufacturers. | 52 | $40.3M Series A | 5 | 11 to 50 | Biotech | Helsinki, Finland | Marketing, Software Engineering, Marketing, Branding, Man... | m***a@onego.bio | ||
Peptone We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins. | 52 | $42.5M Series A | 2 | 11 to 50 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | k***l@peptone.io | ||
Phagenesis Developer of neurostimulation system to treat swallowing dysfunction. | 52 | $52.1M Series D | 5 | 11 to 50 | Biotech | Manchester, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | t**********s@phagenesis.com | ||
Precirix Manufacturer of radio-immunotherapeutic drugs for cancer patients. | 52 | $127M Series B | 7 | 11 to 50 | Biotech | Brussels, Belgium | Cybersecurity, Branding, Management Consulting, Sales, Hi... | r***********s@precirix.com | ||
ReViral Biotechnology firm developing antiviral treatments for patients. | 52 | $44.0M Series C | 2 | 11 to 50 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | |||
Synthace Platform for automating life sciences experiments and integrating the resulting data. | 52 | $35.0M Series C | 1 | 11 to 50 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | l*********h@synthace.com | ||
AAVantgarde Bio Gene therapies for inherited retinal disorders. | 52 | $65.2M Series A | 1 | 1 to 10 | Biotech | Milan, Italy | Hiring, Marketing, Software Engineering, Cybersecurity, B... | n**************u@aavantgardebio.com | ||
AstronauTx Clinical-stage research for alzheimer’s disease. | 52 | $66.5M Series A | 5 | 1 to 10 | Biotech | Reading, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | d*******s@astronautx.bio | ||
AgomAb Therapeutics Drug discovery platform for fibrotic diseases. | 52 | $196M Series C | 9 | 1 to 10 | Biotech | Ghent, Belgium | Cybersecurity, Branding, Management Consulting, Sales, Hi... | p************i@agomab.com | ||
Calluna Pharma Developer of therapies for inflammatory and fibrotic diseases. | 52 | $81.7M Series A | 4 | 11 to 50 | Biotech | Oslo, Norway | Cybersecurity, Branding, Management Consulting, Sales, Hi... | j**********n@callunapharma.com | ||
Enterprise Therapeutics Developer of drugs to treat respiratory diseases. | 52 | $38.6M Series B | 7 | 11 to 50 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | m****n@enterprisetherapeutics.com | ||
Bioptimus Developer of a universal AI foundation model for biology. | 52 | $35.0M Seed | 4 | 1 to 10 | Biotech | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | |||
Quantistry Cloud-native chemical simulation platform. | 52 | $3.3M Seed | 3 | 11 to 50 | Biotech | Berlin, Germany | Design, Software Engineering, Sales, Marketing, Cybersecu... | m************t@quantistry.com | ||
CN Bio Provider of single and multi-organ microphysiological systems. | 52 | $21.0M Series B | 1 | 101 to 250 | Biotech | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | |||
May Health PCOS infertility treatment developer. | 52 | $35.8M Series B | 4 | 1 to 10 | Biotech | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | |||
Biophta Preclinical biotech company developing technology for the treatment of eye diseases. | 52 | $7.0M Seed | 4 | 1 to 10 | Biotech | Paris, France | Design, Software Engineering, Sales, Marketing, Cybersecu... | |||
DnaNudge Platform guiding people towards better lifestyles based on their DNA. | 50 | $60.0M Series A | 11 to 50 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | m***a@dnanudge.com | |||
InnovaFeed Biotech firm producing insect-based protein for animal feed. | 50 | $250M Series D | 101 to 250 | Biotech | Paris, France | Cybersecurity, Branding, Management Consulting, Sales, Hi... | b************i@innovafeed.com | |||
SparingVision Biotechnology company focused on developing genomic medicines to treat blinding inherited retinal diseases. | 50 | $52.8M Series A | 1 | 1 to 10 | Biotech | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | s**************l@sparingvision.com | ||
Pulmocide Inhaled medicines developed for treating viral and fungal respiratory infections. | 50 | $52.0M Unknown | 11 to 50 | Biotech | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | d*****s@pulmocide.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.